These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

530 related articles for article (PubMed ID: 22253394)

  • 1. Survival without disability to age 5 years after neonatal caffeine therapy for apnea of prematurity.
    Schmidt B; Anderson PJ; Doyle LW; Dewey D; Grunau RE; Asztalos EV; Davis PG; Tin W; Moddemann D; Solimano A; Ohlsson A; Barrington KJ; Roberts RS;
    JAMA; 2012 Jan; 307(3):275-82. PubMed ID: 22253394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Academic Performance, Motor Function, and Behavior 11 Years After Neonatal Caffeine Citrate Therapy for Apnea of Prematurity: An 11-Year Follow-up of the CAP Randomized Clinical Trial.
    Schmidt B; Roberts RS; Anderson PJ; Asztalos EV; Costantini L; Davis PG; Dewey D; D'Ilario J; Doyle LW; Grunau RE; Moddemann D; Nelson H; Ohlsson A; Solimano A; Tin W;
    JAMA Pediatr; 2017 Jun; 171(6):564-572. PubMed ID: 28437520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term effects of caffeine therapy for apnea of prematurity.
    Schmidt B; Roberts RS; Davis P; Doyle LW; Barrington KJ; Ohlsson A; Solimano A; Tin W;
    N Engl J Med; 2007 Nov; 357(19):1893-902. PubMed ID: 17989382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylxanthine therapy for apnea of prematurity: evaluation of treatment benefits and risks at age 5 years in the international Caffeine for Apnea of Prematurity (CAP) trial.
    Schmidt B
    Biol Neonate; 2005; 88(3):208-13. PubMed ID: 16210843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurobehavioral Outcomes 11 Years After Neonatal Caffeine Therapy for Apnea of Prematurity.
    Mürner-Lavanchy IM; Doyle LW; Schmidt B; Roberts RS; Asztalos EV; Costantini L; Davis PG; Dewey D; D'Ilario J; Grunau RE; Moddemann D; Nelson H; Ohlsson A; Solimano A; Tin W; Anderson PJ;
    Pediatrics; 2018 May; 141(5):. PubMed ID: 29643070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of targeting higher vs lower arterial oxygen saturations on death or disability in extremely preterm infants: a randomized clinical trial.
    Schmidt B; Whyte RK; Asztalos EV; Moddemann D; Poets C; Rabi Y; Solimano A; Roberts RS;
    JAMA; 2013 May; 309(20):2111-20. PubMed ID: 23644995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Caffeine therapy for apnea of prematurity.
    Schmidt B; Roberts RS; Davis P; Doyle LW; Barrington KJ; Ohlsson A; Solimano A; Tin W;
    N Engl J Med; 2006 May; 354(20):2112-21. PubMed ID: 16707748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction in developmental coordination disorder with neonatal caffeine therapy.
    Doyle LW; Schmidt B; Anderson PJ; Davis PG; Moddemann D; Grunau RE; O'Brien K; Sankaran K; Herlenius E; Roberts R;
    J Pediatr; 2014 Aug; 165(2):356-359.e2. PubMed ID: 24840756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Question 1 Does caffeine treatment for apnoea of prematurity improve neurodevelopmental outcome in later life?
    Winckworth LC; Powell E
    Arch Dis Child; 2010 Sep; 95(9):757-9. PubMed ID: 20716677
    [No Abstract]   [Full Text] [Related]  

  • 10. Prediction of Late Death or Disability at Age 5 Years Using a Count of 3 Neonatal Morbidities in Very Low Birth Weight Infants.
    Schmidt B; Roberts RS; Davis PG; Doyle LW; Asztalos EV; Opie G; Bairam A; Solimano A; Arnon S; Sauve RS; ;
    J Pediatr; 2015 Nov; 167(5):982-6.e2. PubMed ID: 26318030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term neurodevelopment outcome of caffeine versus aminophylline therapy for apnea of prematurity.
    Khurana S; Shivakumar M; Sujith Kumar Reddy GV; Jayashree P; Ramesh Bhat Y; Lewis LES
    J Neonatal Perinatal Med; 2017; 10(4):355-362. PubMed ID: 29286928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved survival rates with increased neurodevelopmental disability for extremely low birth weight infants in the 1990s.
    Wilson-Costello D; Friedman H; Minich N; Fanaroff AA; Hack M
    Pediatrics; 2005 Apr; 115(4):997-1003. PubMed ID: 15805376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Developmental sequel of prematurity].
    Helwich E
    Med Wieku Rozwoj; 2003; 7(3 Suppl 1):25-9. PubMed ID: 15537241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in neurodevelopmental outcomes at 18 to 22 months' corrected age among infants of less than 25 weeks' gestational age born in 1993-1999.
    Hintz SR; Kendrick DE; Vohr BR; Poole WK; Higgins RD;
    Pediatrics; 2005 Jun; 115(6):1645-51. PubMed ID: 15930228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurodevelopmental outcome in extremely preterm infants at 2.5 years after active perinatal care in Sweden.
    Serenius F; Källén K; Blennow M; Ewald U; Fellman V; Holmström G; Lindberg E; Lundqvist P; Maršál K; Norman M; Olhager E; Stigson L; Stjernqvist K; Vollmer B; Strömberg B;
    JAMA; 2013 May; 309(17):1810-20. PubMed ID: 23632725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changing long-term outcomes for infants 500-999 g birth weight in Victoria, 1979-2005.
    Doyle LW; Roberts G; Anderson PJ;
    Arch Dis Child Fetal Neonatal Ed; 2011 Nov; 96(6):F443-7. PubMed ID: 21393312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Intellectual and motor development of extremely low birth weight (≤1000 g) children in the 7th year of life; a multicenter, cross-sectional study of children born in the Malopolska voivodship between 2002 and 2004].
    Kwinta P; Klimek M; Grudzień A; Nitecka M; Profus K; Gasińska M; Pawlik D; Lauterbach R; Olechowski W; Pietrzyk JJ
    Med Wieku Rozwoj; 2012; 16(3):222-31. PubMed ID: 23378400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of neurodevelopmental impairment for outborn extremely preterm infants in an Australian regional network.
    Mahoney K; Bajuk B; Oei J; Lui K; Abdel-Latif ME;
    J Matern Fetal Neonatal Med; 2017 Jan; 30(1):96-102. PubMed ID: 26957041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of intraventricular hemorrhage and posthemorrhagic hydrocephalus in a population-based cohort of very preterm infants born to residents of Nova Scotia from 1993 to 2010.
    Radic JA; Vincer M; McNeely PD
    J Neurosurg Pediatr; 2015 Jun; 15(6):580-8. PubMed ID: 26030329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On the caffeination of prematurity.
    Stevenson DK
    N Engl J Med; 2007 Nov; 357(19):1967-8. PubMed ID: 17989390
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 27.